Treatment Strategy for Rifampin-Susceptible Tuberculosis.

Abstract

A strategy involving initial treatment with an 8-week bedaquiline-linezolid regimen was noninferior to standard treatment for tuberculosis with respect to clinical outcomes. The strategy was associated with a shorter total duration of treatment and with no evident safety concerns. (Funded by the Singapore National Medical Research Council and others; TRUNCATE-TB ClinicalTrials.gov number, NCT03474198.).

Access to Document

Other files and links

• Link to publication in Scopus
• Open Access Version Available

Fingerprint